There are 2789 resources available
Mechanisms of resistance and novel strategies
Presenter: Céline Mascaux
Session: Refining the use of immune-checkpoint inhibition
Resources:
Abstract
Slides
Webcast
Do we have any idea how to use these drugs in oncogene addicted patients yet?
Presenter: Julien Mazieres
Session: Refining the use of immune-checkpoint inhibition
Resources:
Slides
Webcast
Introduction
Presenter: Sanjay Popat
Session: The year in review of molecularly driven NSCLC
Resources:
Slides
Broadening the horizons: EGFR, ALK, ROS-1, BRAF
Presenter: Christine Lovly
Session: The year in review of molecularly driven NSCLC
Resources:
Slides
Webcast
Opening new horizons: RET, NTRK, MET, HER2…
Presenter: Herbert Ho Fung Loong
Session: The year in review of molecularly driven NSCLC
Resources:
Slides
Webcast
How do we identify resistance mechanisms?
Presenter: Joop De Langen
Session: The year in review of molecularly driven NSCLC
Resources:
Slides
Webcast
Introduction
Presenter: Silke Gillessen
Session: Earlier treatment in prostate cancer: How can we maximize the therapeutic index?
Resources:
Slides
Webcast
Evidence-based treatment options in biochemically relapsed prostate cancer
Presenter: Nicolas Mottet
Session: Earlier treatment in prostate cancer: How can we maximize the therapeutic index?
Resources:
Slides
Webcast
The role of imaging in selecting treatment
Presenter: Piet Ost
Session: Earlier treatment in prostate cancer: How can we maximize the therapeutic index?
Resources:
Slides
Webcast
Quality of life (QoL) and long-term comorbidities
Presenter: Heather Payne
Session: Earlier treatment in prostate cancer: How can we maximize the therapeutic index?
Resources:
Slides
Webcast